- AU$226.82m
- AU$256.56m
- $5.62m
Annual balance sheet for Novonix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | fx Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 102 | 143 | 78.7 | 42.6 | 79.9 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.53 | 2.46 | 3.56 | 8.16 | 2.12 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 108 | 162 | 89.2 | 57.3 | 89.2 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 31.6 | 112 | 144 | 156 | 181 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 152 | 303 | 263 | 226 | 283 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4.01 | 7.9 | 7.84 | 46.2 | 83.6 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 13.8 | 51.9 | 79.4 | 88.5 | 121 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 138 | 251 | 184 | 138 | 162 |
| Total Liabilities & Shareholders' Equity | 152 | 303 | 263 | 226 | 283 |
| Total Common Shares Outstanding |